FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


Deutsche Bank Agents TriplePoint Venture Growth BDC $200MM Facility

January 29, 2016, 07:30 AM
Filed Under: Investment Financing

TriplePoint Venture Growth BDC Corp., a leading financing provider to venture growth stage companies backed by a select group of venture capital firms in the technology, life sciences and other high growth industries, has renewed its existing $200 million revolving credit facility. In addition to extending the revolving period of the credit facility from February 21, 2016 to February 21, 2018 and the maturity date of the credit facility from February 21, 2017 to February 21, 2019, the renewal also included reducing the applicable margin above the base rates specified in the credit facility during the revolving period from 3.50% to 3.00%. Deutsche Bank AG, New York Branch serves as administrative agent and as a lender together with KeyBank National Association, EverBank Commercial Lender Finance, Inc., and AloStar Bank of Commerce.

“We appreciate the continued support of our lenders. This renewal adds to our financial strength and flexibility and will help us take advantage of the attractive opportunities we are seeing in the venture lending market,” said Harold Zagunis, chief financial officer of the Company. “In addition, the reduced interest rate, combined with the lack of a LIBOR floor provision, will further benefit our shareholders as it reduces our cost of debt capital.”

The company is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. It was formed to expand the venture growth stage business segment of TriplePoint Capital LLC. The company’s investment objective is to maximize its total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by primarily lending with warrants to venture growth stage companies focused in technology, life sciences and other high growth industries backed by a select group of leading venture capital investors.

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.